Potential of Microvascular Reperfusion with Adjunctive Pharmacological Intervention
- 16 Downloads
One of the major limitations of reperfusion therapy in acute myocardial infarction (AMI) is the presentation of no-reflow phenomenon. In 25 to 30% of patients with AMI, myocardial blood flow is occasionally profoundly reduced, even after coronary recanalisation, because of microvascular dysfunction - so-called no-reflow phenomenon. Patients with this phenomenon are regarded as a high risk group among patients with reperfused AMI.
Clinical studies using myocardial contrast echocardiography have demonstrated that intracoronary injection of calcium antagonists or potassium channel agonists in conjunction with coronary reperfusion can augment myocardial blood flow and that this was associated with better functional and clinical outcomes than with percutaneous transluminal coronary angioplasty alone. Thus, it is possible to prevent reperfusion injury and improve cardiac function using a adjunctive pharmacological intervention, either intravenously or by infusion directly into the coronary artery.
KeywordsAcute Myocardial Infarction Myocardial Blood Flow Abciximab Nicorandil Microvascular Dysfunction
- 2.Gruppo Italiano per lo Studio Delia Streptkinesi Nell E Infarct (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; I: 397–401Google Scholar
- 11.Lepper W, Hoffmann R, Kamp O, et al. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angiography in patients with acute myocardial infarction. Circulation 2000 May 23; 101(20): 2368–74PubMedCrossRefGoogle Scholar
- 14.Mahaffey KW, Puma JA, Barbagelata A, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomised, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 1999; 34(6): 1711–20PubMedCrossRefGoogle Scholar
- 19.Kitakaze M, Minamino T, Node K, et al. Role of activation of ectopic 5’-nucleotidase in the cardioprotection mediated by opening K+ channel. Am J Physiol 1995; 26: 477–84Google Scholar
- 24.Brener SJ, Barr LA, Burchenal JE, et al. Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty: RAPPORT investigators. ReoPro and primary PTCA organization and randomized trial. J Am Coll Cardiol 1999; 84(6): 728–30, A8Google Scholar